MedElevator Войти в исследования
← Поиск публикаций

DOI 10.18502/cjn.v23i1.16432

Медицинская библиотека · Current journal of neurology · 2024

Anticoagulation in the management of septic cavernous sinus thrombosis secondary to rhino-orbito-cerebral mucormycosis: A retrospective real-world experience.

Amani Kiana, Shahbazi Mojtaba, Behkar Atefeh, Farahmand Ghasem, Ghafouri Shima, Heydari Sanaz, Kaeedi Maryam, Magrouni Hana, Alizadeh Fatemeh, Ghabaee Mojdeh, Sarraf Payam, Tafakhori Abbas, Amirifard Hamed, Ranji-Burachaloo Sakineh, Mohammadianinejad Seyed Ehsan, Jameie Melika, Harirchian Mohammad Hossein

СтатьяПеревод в очереди

Аннотация

Background

COVID-19 was associated with an increased number of patients with mucormycosis (MCR), followed by septic cavernous sinus thrombosis (SCST). We evaluated the association between anticoagulation (AC) and mortality/morbidity of COVID-19-associated MCR (CAM)-induced SCST.

Methods

In this retrospective study, neurological sequelae, functional outcomes, and in-hospital mortality were compared between AC receivers and non-receivers. In addition, the association between AC and survivability was examined.

Results

Twenty-nine patients (17 male; mean age: 51.27 years) with CAM-induced SCST were included in the study. The median intervals between COVID-19 and MCR, and COVID-19 and SCST were 19 and 27 days, respectively. Among AC recipients, the interval between SCST and AC initiation was 18 days, with an AC duration of 37 days. Baseline and management-related characteristics were comparable between AC recipients and non-recipients (P > 0.050). AC receivers (n = 15) and non-receivers (n = 14) did not significantly differ in terms of the proportion of sequelae (6/15 vs. 5/14; P = 1.000), complete recovery (2/15 vs. 4/14; P = 0.687), and in-hospital mortality (3/15 vs. 3/14; P > 0.999). Nevertheless, AC recipients had a longer hospital stay (72.0 vs. 35.5; P = 0.016). AC-related characteristics (AC receiving, type, early initiation, and duration) were not significantly different between survivors and non-survivors, or between recovered and disabled patients.

Conclusion

In our study, CAM-induced SCST in-hospital mortality/morbidity did not differ between AC receivers and non-receivers. AC characteristics were not different between survivors and non-survivors, or recovered and disabled patients. However, the small sample size may have limited the ability to detect significant differences, leading to inconclusive results.

Для цитирования: Amani Kiana, Shahbazi Mojtaba, Behkar Atefeh, Farahmand Ghasem, Ghafouri Shima, Heydari Sanaz, Kaeedi Maryam, Magrouni Hana, Alizadeh Fatemeh, Ghabaee Mojdeh, Sarraf Payam, Tafakhori Abbas, Amirifard Hamed, Ranji-Burachaloo Sakineh, Mohammadianinejad Seyed Ehsan, Jameie Melika, Harirchian Mohammad Hossein. Anticoagulation in the management of septic cavernous sinus thrombosis secondary to rhino-orbito-cerebral mucormycosis: A retrospective real-world experience.. Current journal of neurology. 2024. DOI: 10.18502/cjn.v23i1.16432.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.